Galderma Laboratories L.P. v. Amneal Pharmaceuticals LLC

Application Number	Patent Number	External Links
-	US7211267	Espacenet Google Patents
-	US7749532	Espacenet Google Patents
-	US8206740	Espacenet Google Patents
-	US8394405	Espacenet Google Patents
-	US8394406	Espacenet Google Patents
-	US8470364	Espacenet Google Patents
-	US8709478	Espacenet Google Patents
-	US7232572	Espacenet Google Patents
-	US8603506	Espacenet Google Patents
-	US9241946	Espacenet Google Patents

COMPLAINT filed against Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-19004402.) - filed by Nestle Skin Health S.A., Galderma Laboratories L.P., TCD Royalty Sub LLC.(Attachments: # 1 Exhibit A-F, # 2 Exhibit G, # 3 Exhibit H, # 4 Exhibit I-J, # 5 Civil Cover Sheet)aah) (Entered: 03/31/2016)

2016-03-31

1

Download

COMPLAINT filed against Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-19004402.) - filed by Nestle Skin Health S.A., Galderma Laboratories L.P., TCD Royalty Sub LLC.(Attachments: # 1 Exhibit A-F, # 2 Exhibit G, # 3 Exhibit H, # 4 Exhibit I-J, # 5 Civil Cover Sheet)aah) (Entered: 03/31/2016)

2016-03-31

2

View

COMPLAINT filed against Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-19004402.) - filed by Nestle Skin Health S.A., Galderma Laboratories L.P., TCD Royalty Sub LLC.(Attachments: # 1 Exhibit A-F, # 2 Exhibit G, # 3 Exhibit H, # 4 Exhibit I-J, # 5 Civil Cover Sheet)aah) (Entered: 03/31/2016)

2016-03-31

2

View

COMPLAINT filed against Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-19004402.) - filed by Nestle Skin Health S.A., Galderma Laboratories L.P., TCD Royalty Sub LLC.(Attachments: # 1 Exhibit A-F, # 2 Exhibit G, # 3 Exhibit H, # 4 Exhibit I-J, # 5 Civil Cover Sheet)aah) (Entered: 03/31/2016)

2016-03-31

2

View

COMPLAINT filed against Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-19004402.) - filed by Nestle Skin Health S.A., Galderma Laboratories L.P., TCD Royalty Sub LLC.(Attachments: # 1 Exhibit A-F, # 2 Exhibit G, # 3 Exhibit H, # 4 Exhibit I-J, # 5 Civil Cover Sheet)aah) (Entered: 03/31/2016)

2016-03-31

2

View

COMPLAINT filed against Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-19004402.) - filed by Nestle Skin Health S.A., Galderma Laboratories L.P., TCD Royalty Sub LLC.(Attachments: # 1 Exhibit A-F, # 2 Exhibit G, # 3 Exhibit H, # 4 Exhibit I-J, # 5 Civil Cover Sheet)aah) (Entered: 03/31/2016)

2016-03-31

2

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (aah) (Entered: 03/31/2016)

2016-03-31

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/18/2016. Date of Expiration of Patent: See attached form.Thirty Month Stay Deadline: 8/18/2018. (aah) (Entered: 03/31/2016)

2016-03-31

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,211,267 B2; 7,232,572 B2; 8,603,506 B2; 9,241,946 B2; 7,749,532 B2;(aah) (Entered: 03/31/2016)

2016-03-31

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Galderma General, L.L.C., Corporate Parent Galderma Limited, L.L.C., Corporate Parent Nestle Skin Health U.S. Inc. for Galderma Laboratories L.P. filed by Galderma Laboratories L.P.(aah) (Entered: 03/31/2016)

2016-03-31

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Nestle S.A. for Nestle Skin Health S.A. filed by Nestle Skin Health S.A.(aah) (Entered: 03/31/2016)

2016-03-31

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Royalty Opportunities S.a.r.l for TCD Royalty Sub LLC filed by TCD Royalty Sub LLC.(aah) (Entered: 03/31/2016)

2016-03-31

1

View

Summons Issued with Magistrate Consent Notice attached as to Amneal Pharmaceuticals Co. (I) Pvt. Ltd. on 3/31/2016; Amneal Pharmaceuticals LLC on 3/31/2016. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them.(aah)

2016-03-31

1

No Actions

Summons Issued

2016-03-31

1

No Actions

Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)

2016-04-06

1

No Actions

Case Assigned/Reassigned

2016-04-06

1

No Actions

SUMMONS Returned Executed by Nestle Skin Health S.A., Galderma Laboratories L.P., TCD Royalty Sub LLC. Amneal Pharmaceuticals LLC served on 4/20/2016, answer due 5/11/2016. (Noreika, Maryellen) (Entered: 04/22/2016)

2016-04-22

1

View

SUMMONS Returned Executed by Nestle Skin Health S.A., Galderma Laboratories L.P., TCD Royalty Sub LLC. Amneal Pharmaceuticals Co. (I) Pvt. Ltd. served on 4/20/2016, answer due 5/11/2016. (Noreika, Maryellen) (Entered: 04/22/2016)

2016-04-22

1

View

NOTICE of Change of Address by Maryellen Noreika (Noreika, Maryellen) (Entered: 05/05/2016)

2016-05-05

1

View

ANSWER to 1 Complaint,, COUNTERCLAIM against Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Gaza, Anne) (Entered: 05/11/2016)

2016-05-11

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amneal Pharmaceuticals Holding Company, LLC, Corporate Parent Amneal Holdings, LLC for Amneal Pharmaceuticals LLC; Corporate Parent Amneal Pharmaceuticals LLC for Amneal Pharmaceuticals Co. (I) Pvt. Ltd. filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 05/11/2016)

2016-05-11

1

View

MOTION for Pro Hac Vice Appearance of Attorney Kevin Warner and Attorney Karalena M. Guerrieri - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 05/11/2016)

2016-05-11

1

View

MOTION for Pro Hac Vice Appearance of Attorney Maureen L. Rurka - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 05/12/2016)

2016-05-12

1

View

SO ORDERED, re 13 MOTION for Pro Hac Vice Appearance of Attorney Kevin Warner and Attorney Karalena M. Guerrieri filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 5/12/16. (ntl)

2016-05-12

1

No Actions

SO ORDERED

2016-05-12

1

No Actions

SO ORDERED, re 14 MOTION for Pro Hac Vice Appearance of Attorney Maureen L. Rurka filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 5/16/16. (ntl)

2016-05-16

1

No Actions

Pro Hac Vice Attorney Kevin E. Warner for Amneal Pharmaceuticals Co. (I) Pvt. Ltd., and Amneal Pharmaceuticals LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (klc)

2016-05-16

1

No Actions

SO ORDERED

2016-05-16

1

No Actions

Add Attorneys - PHV only

2016-05-16

1

No Actions

Pro Hac Vice Attorney Karalena M. Guerrieri for Amneal Pharmaceuticals Co. (I) Pvt. Ltd.,Karalena M. Guerrieri for Amneal Pharmaceuticals LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

2016-05-17

1

No Actions

Add Attorneys - PHV only

2016-05-17

1

No Actions

ANSWER to 11 Answer to Complaint, Counterclaim by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 06/06/2016)

2016-06-06

1

View

MOTION for Judgment on the Pleadings - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Attachments: # 1 Text of Proposed Order)(Gaza, Anne) (Entered: 06/16/2016)

2016-06-16

1

View

OPENING BRIEF in Support re 16 MOTION for Judgment on the Pleadings filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.Answering Brief/Response due date per Local Rules is 7/5/2016. (Gaza, Anne) (Entered: 06/16/2016)

2016-06-16

1

View

ANSWERING BRIEF in Opposition re 16 MOTION for Judgment on the Pleadings filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.Reply Brief due date per Local Rules is 7/15/2016. (Attachments: # 1 Exhibits A-E)(Blumenfeld, Jack) (Entered: 07/05/2016)

2016-07-05

1

View

STIPULATION TO EXTEND TIME for Defendants to file a Reply Brief in support of their Motion for Partial Judgment on the Pleadings to July 22, 2106 - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Gaza, Anne) (Entered: 07/12/2016)

2016-07-12

1

View

MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr., Evan D. Diamond, Vanessa Y. Yen and Andrew T. Kessel - filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 07/12/2016)

2016-07-12

1

View

SO ORDERED, re 20 MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr., Evan D. Diamond, Vanessa Y. Yen and Andrew T. Kessel filed by Galderma Laboratories L.P., TCD Royalty Sub LLC, Nestle Skin Health S.A. Signed by Judge Leonard P. Stark on 7/13/16. (ntl)

2016-07-13

1

No Actions

SO ORDERED

2016-07-13

1

No Actions

SO ORDERED, re 19 STIPULATION TO EXTEND TIME for Defendants to file a Reply Brief in support of their Motion for Partial Judgment on the Pleadings to July 22, 2106 filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 7/13/16. (ntl)

2016-07-14

1

No Actions

SO ORDERED

2016-07-14

1

No Actions

REPLY BRIEF re 16 MOTION for Judgment on the Pleadings filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Gaza, Anne) (Entered: 07/22/2016)

2016-07-22

1

View

REQUEST for Oral Argument by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC re 16 MOTION for Judgment on the Pleadings . (Gaza, Anne) (Entered: 07/22/2016)

2016-07-22

1

View

ORAL ORDER: IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposal, including a proposal for the length and timing of trial, to the Court no later than September 2, 2016. The parties are to review the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Stark, New Patent Procedures). ORDERED by Judge Leonard P. Stark on 8/19/16. (ntl) (Entered: 08/19/2016)

2016-08-19

1

View

Order

2016-08-19

1

No Actions

PROPOSED ORDER // Scheduling Order by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Exhibit 1, # 2 Cover Letter)(Noreika, Maryellen) (Main Document 24 replaced on 9/8/2016) (ntl). (Attachment 1 replaced on 9/8/2016) (ntl). (Entered: 09/02/2016)

2016-09-02

1

View

CORRECTING ENTRY: Corrected documents added to D.I. 24 per request of counsel. (ntl)

2016-09-08

1

No Actions

- CORRECTING ENTRY

2016-09-08

1

No Actions

STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to September 21, 2016 - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 09/14/2016)

2016-09-14

1

View

NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Identifying Defendants' Accused Products and Plaintiffs' Asserted Patents filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 09/16/2016)

2016-09-16

1

View

STIPULATION TO EXTEND TIME for parties to submit agreed modifications, if any, to the Default Standard for Discovery, including ESI to September 21, 2016 - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Gaza, Anne) (Entered: 09/16/2016)

2016-09-16

1

View

SO ORDERED, re 25 STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to September 21, 2016 filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 9/19/16. (ntl)

2016-09-19

1

No Actions

SO ORDERED

2016-09-19

1

No Actions

STIPULATION TO EXTEND TIME for the parties to submit (1) agreed modifications, if any, to the Default Standard for Discovery, Including Discovery of Electronically Stored Information (ESI), pursuant to Paragraph 1 of the parties' Proposed Scheduling Order (D.I. 24); and (2) a proposed Protective Order; pursuant to Paragraph 3 of the parties' Proposed Scheduling Order to September 28, 2106 - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 09/21/2016)

2016-09-21

1

View

NOTICE OF SERVICE of Defendants' Requests for Production of Documents and Things (Nos. 1-34) to Plaintiffs filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 09/21/2016)

2016-09-21

1

View

STIPULATION TO EXTEND TIME for the parties to make their ESI Initial Disclosures, pursuant to the Proposed Scheduling Order to September 28, 2016 - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 09/23/2016)

2016-09-23

1

View

SO ORDERED, re 28 STIPULATION TO EXTEND TIME for the parties to submit (1) agreed modifications, if any, to the Default Standard for Discovery, Including Discovery of Electronically Stored Information (ESI), pursuant to Paragraph 1 of the parties' Proposed Schedul filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd., 27 STIPULATION TO EXTEND TIME for parties to submit agreed modifications, if any, to the Default Standard for Discovery, including ESI to September 21, 2016 filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 9/22/16. (ntl)

2016-09-23

1

No Actions

SO ORDERED

2016-09-23

1

No Actions

SO ORDERED, re 30 STIPULATION TO EXTEND TIME for the parties to make their ESI Initial Disclosures, pursuant to the Proposed Scheduling Order to September 28, 2016 filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 9/26/16. (ntl)

2016-09-26

1

No Actions

SO ORDERED

2016-09-26

1

No Actions

NOTICE OF SERVICE of Defendants' Initial Disclosures Under Paragraph 3 of the Stipulated Standard for Discovery filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 09/28/2016)

2016-09-28

1

View

NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Parties' Proposed ESI Order filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 09/28/2016)

2016-09-28

1

View

PROPOSED ORDER // Protective Order by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 09/28/2016)

2016-09-28

1

View

PROPOSED ORDER Regarding Discovery, Including Discovery of Electronically Stored Information ("ESI") by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 09/28/2016)

2016-09-28

1

View

SO ORDERED, re 34 Stipulated Order Regarding Discovery, Including Discovery of Electronically Stored Information ("ESI"); 33 Stipulated Protective Order. Signed by Judge Leonard P. Stark on 10/4/16. (ntl)

2016-10-04

1

No Actions

SO ORDERED

2016-10-04

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Joanna F. Cornwell, Esquire - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 10/07/2016)

2016-10-07

1

View

NOTICE OF SERVICE of Defendants core technical documents, in accordance with Paragraph 7(b) of the Proposed Scheduling Order filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 10/07/2016)

2016-10-07

1

View

ORAL ORDER: IT IS HEREBY ORDERED that a Rule 16 scheduling teleconference has been scheduled for October 13, 2016 at 11:15 a.m. Plaintiff's counsel shall initiate the teleconference call to 302-573-4571. No further submissions are needed. ORDERED by Judge Leonard P. Stark on 10/11/16. (ntl) (Entered: 10/11/2016)

2016-10-11

1

View

Order Setting Scheduling Conference

2016-10-11

1

No Actions

Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding request to reschedule Rule 16 conference. (Noreika, Maryellen) (Main Document 38 replaced on 10/12/2016) (ntl). (Entered: 10/12/2016)

2016-10-12

1

View

CORRECTING ENTRY: Corrected letter added to D.I. 38 per request of counsel. (ntl)

2016-10-12

1

No Actions

SO ORDERED, re 35 MOTION for Pro Hac Vice Appearance of Attorney Joanna F. Cornwell, Esquire filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 10/12/16. (ntl)

2016-10-12

1

No Actions

- CORRECTING ENTRY

2016-10-12

1

No Actions

SO ORDERED

2016-10-12

1

No Actions

ORAL ORDER: IT IS HEREBY ORDERED that the Telephonic Scheduling Conference set for today is CANCELLED and is hereby re-scheduled for October 28, 2016 at 12:00 p.m. ORDERED by Judge Leonard P. Stark on 10/13/16. (ntl) (Entered: 10/13/2016)

2016-10-13

1

View

Order Setting Scheduling Conference

2016-10-13

1

No Actions

ORAL ORDER: IT IS HEREBY ORDERED that the Court will hear oral argument on the pending motion (D.I. 16) on November 9, 2016 beginning at 2:00 p.m. Each side will be allocated up to 45 minutes to present its argument. ORDERED by Judge Leonard P. Stark on 10/21/16. (ntl) (Entered: 10/21/2016)

2016-10-21

1

View

NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Requests for Production of Documents and Things (Nos. 1-34) filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 10/21/2016)

2016-10-21

1

View

~Util - Set Hearings AND Order

2016-10-21

1

No Actions

ORAL ORDER: IT IS HEREBY ORDERED that the Scheduling Teleconference scheduled for October 28 will begin at 11:30 a.m. ORDERED by Judge Leonard P. Stark on 10/26/16. (ntl) (Entered: 10/26/2016)

2016-10-26

1

View

~Util - Set Hearings AND Order

2016-10-26

1

No Actions

Letter to The Honorable Leonard P. Stark from Anne Shea Gaza regarding October 28, 2016 Rule 16 Teleconference. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Gaza, Anne) (Entered: 10/27/2016)

2016-10-27

1

View

PROPOSED ORDER -- Joint Proposed Scheduling Order -- re 43 Letter by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Gaza, Anne) (Entered: 10/27/2016)

2016-10-27

1

View

Minute Entry for proceedings held before Judge Leonard P. Stark - Scheduling Teleconference held on 10/28/2016. (Court Reporter B. Gaffigan.) (ntl)

2016-10-28

1

No Actions

PROPOSED ORDER -- Scheduling Order -- by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld enclosing order)(Blumenfeld, Jack) (Entered: 11/01/2016)

2016-11-01

1

View

Scheduling Conference

2016-11-03

1

No Actions

Official Transcript of Scheduling Telephone Conference held on October 28, 2016 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 11/28/2016. Redacted Transcript Deadline set for 12/8/2016. Release of Transcript Restriction set for 2/6/2017.((bpg) (Entered: 11/07/2016)

2016-11-07

1

View

ORAL ORDER: For the reasons stated in Court at the conclusion of the hearing today, IT IS HEREBY ORDERED that Amneals motion for judgment on the pleadings (D.I. 16) (i) of non-infringement of the Ashley I patents under collateral estoppel is DENIED WITHOUT PREJUDICE and (ii) of invalidity of the Ashley II patents under 35 U.S.C. § 101 is DENIED. ORDERED by Judge Leonard P. Stark on 11/9/2016. (ntl) (Entered: 11/09/2016)

2016-11-09

1

View

Minute Entry for proceedings held before Judge Leonard P. Stark - Oral Argument held on 11/9/2016. (Court Reporter B. Gaffigan.) (etg, )

2016-11-09

1

No Actions

Order

2016-11-09

1

No Actions

SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Discovery due by 5/25/2017. Status Report due by 1/20/2017. Claim Construction Opening Brief due by 1/25/2017. Claim Construction Answering Brief due by 2/23/2017. A Markman Hearing is set for 3/10/2017 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 1/25/2018. A Final Pretrial Conference is set for 2/2/2018 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. A 5-day Bench Trial is set for 2/12/2018 at 08:30 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 11/8/16. (ntl) (Entered: 11/10/2016)

2016-11-10

1

View

Oral Argument

2016-11-10

1

No Actions

ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 11/28/2016 at 11:00 AM before Chief Magistrate Judge Mary Pat Thynge to discuss ADR. Ordered by Judge Mary Pat Thynge on 11/14/16. (cak) (Entered: 11/14/2016)

2016-11-14

1

View

NOTICE OF SERVICE of Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals Co. (I) Pvt. Ltd's Initial Disclosures Pursuant to Rule 26(a)(1) filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 11/14/2016)

2016-11-14

1

View

NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 11/14/2016)

2016-11-14

1

View

CASE REFERRED to Chief Magistrate Judge Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak)

2016-11-14

1

No Actions

Case Referred to Mediation - Magistrate Judge only

2016-11-14

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Yousef M. Mian - filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC, Galderma Laboratories, L.P.. (Noreika, Maryellen) (Entered: 11/15/2016)

2016-11-15

1

View

Official Transcript of Oral Argument Hearing held on November 9, 2016 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone No. (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/9/2016. Redacted Transcript Deadline set for 12/19/2016. Release of Transcript Restriction set for 2/16/2017. (bpg) (Entered: 11/18/2016)

2016-11-18

1

View

NOTICE OF SERVICE of Plaintiffs' Initial Infringement Claim Chart filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 11/18/2016)

2016-11-18

1

View

NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 11/18/2016)

2016-11-18

1

View

ORAL ORDER: A teleconference has been scheduled for 5/15/17 at 10:00 AM Eastern Time with Judge Thynge. Defense counsel shall initiate the teleconference call. Ordered by Judge Mary Pat Thynge on 11/28/16. (cak) (Entered: 11/28/2016)

2016-11-28

1

View

Oral Order

2016-11-28

1

No Actions

STIPULATION TO EXTEND TIME for Defendants (Amneal) to produce to Plaintiffs their Initial Invalidity Contentions, pursuant to Paragraph 7(d) of the Scheduling Order to December 22, 2016 - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 12/08/2016)

2016-12-08

1

View

SO ORDERED, re 52 MOTION for Pro Hac Vice Appearance of Attorney Yousef M. Mian filed by Galderma Laboratories L.P., TCD Royalty Sub LLC, Nestle Skin Health S.A., Galderma Laboratories, L.P. Signed by Judge Leonard P. Stark on 12/8/16. (ntl)

2016-12-08

1

No Actions

SO ORDERED, re 57 STIPULATION TO EXTEND TIME for Defendants (Amneal) to produce to Plaintiffs their Initial Invalidity Contentions, pursuant to Paragraph 7(d) of the Scheduling Order to December 22, 2016 filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 12/8/16. (ntl)

2016-12-08

1

No Actions

SO ORDERED

2016-12-08

1

No Actions

SO ORDERED

2016-12-08

1

No Actions

NOTICE OF SERVICE of Defendants' Responses and Objections to Plaintiffs' First Set of Requests for the Production of Documents and Things filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 12/19/2016)

2016-12-19

1

View

STIPULATION TO EXTEND TIME for Defendants (Amneal) to produce to Plaintiffs their Initial Invalidity Contentions to December 23, 2016 - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 12/22/2016)

2016-12-22

1

View

NOTICE OF SERVICE of Defendants' Proposed Claim Construction Terms filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 12/23/2016)

2016-12-23

1

View

NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 12/27/2016)

2016-12-27

1

View

SO ORDERED - re 59 STIPULATION TO EXTEND TIME for Defendants (Amneal) to produce to Plaintiffs their Initial Invalidity Contentions to December 23, 2016 filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 12/27/16. (etg)

2016-12-27

1

No Actions

SO ORDERED

2016-12-27

1

No Actions

CLAIM Construction Chart by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Exhibits 1-6, # 2 Exhibits 7-11, # 3 Exhibits 12-25, # 4 Exhibits 26-35)(Noreika, Maryellen) (Entered: 01/10/2017)

2017-01-10

1

View

EXHIBIT re 62 Claim Construction Chart by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Volume 2 of 3 (Exhibits 36-39))(Noreika, Maryellen) (Entered: 01/10/2017)

2017-01-10

1

View

EXHIBIT re 62 Claim Construction Chart (Volume 3 of 3) by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Exhibits 40-67)(Noreika, Maryellen) (Entered: 01/10/2017)

2017-01-10

1

View

Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding interim status report. (Blumenfeld, Jack) (Entered: 01/20/2017)

2017-01-20

1

View

MOTION for Pro Hac Vice Appearance of Attorney Chloe X. Jiang and Si (Annie) Chen - filed by Galderma Laboratories, L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC, Galderma Laboratories L.P.. (Blumenfeld, Jack) (Entered: 01/20/2017)

2017-01-20

1

View

STIPULATION and [Proposed Order] Regarding Technology Tutorial by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 01/24/2017)

2017-01-24

1

View

MOTION for Pro Hac Vice Appearance of Attorney Lucas L. Kressel - filed by Galderma Laboratories, L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC, Galderma Laboratories L.P.. (Noreika, Maryellen) (Entered: 01/24/2017)

2017-01-24

1

View

SO ORDERED, re (21 in 1:16-cv-01003-LPS, 66 in 1:16-cv-00207-LPS) MOTION for Pro Hac Vice Appearance of Attorney Chloe X. Jiang and Si (Annie) Chen filed by Galderma Laboratories L.P., TCD Royalty Sub LLC, Nestle Skin Health S.A., Galderma Laboratories, L.P. Signed by Judge Leonard P. Stark on 1/24/17. Associated Cases: 1:16-cv-00207-LPS, 1:16-cv-01003-LPS (ntl)

2017-01-24

1

No Actions

SO ORDERED

2017-01-24

1

No Actions

CLAIM CONSTRUCTION OPENING BRIEF filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Main Document 69 replaced on 2/2/2017) (ntl). (Entered: 01/25/2017)

2017-01-25

1

View

[SEALED] CLAIM CONSTRUCTION OPENING BRIEF filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Exhibits A-G)(Noreika, Maryellen) (Entered: 01/25/2017)

2017-01-25

1

View

SO ORDERED, re (23 in 1:16-cv-01003-LPS, 68 in 1:16-cv-00207-LPS) MOTION for Pro Hac Vice Appearance of Attorney Lucas L. Kressel filed by Galderma Laboratories L.P., TCD Royalty Sub LLC, Nestle Skin Health S.A., Galderma Laboratories, L.P. Signed by Judge Leonard P. Stark on 1/26/17. Associated Cases: 1:16-cv-00207-LPS, 1:16-cv-01003-LPS (ntl)

2017-01-26

1

No Actions

SO ORDERED

2017-01-26

1

No Actions

SO ORDERED, re 67 Stipulation and Order Regarding Technology Tutorial filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 1/27/17. (ntl)

2017-01-27

1

No Actions

SO ORDERED

2017-01-27

1

No Actions

NOTICE OF SERVICE of Plaintiffs' Second Set of Requests for the Production of Documents and Things filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 01/30/2017)

2017-01-30

1

View

REDACTED VERSION of 70 Claim Construction Opening Brief by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Exhibit A - G)(Noreika, Maryellen) (Entered: 02/01/2017)

2017-02-01

1

View

CORRECTING ENTRY: Corrected document added to D.I. 69 per request of counsel. (ntl)

2017-02-02

1

No Actions

- CORRECTING ENTRY

2017-02-02

1

No Actions

Joint Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding Claim Construction Hearing. (Noreika, Maryellen) (Entered: 02/23/2017)

2017-02-23

1

View

CLAIM CONSTRUCTION ANSWERING BRIEF filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 02/23/2017)

2017-02-23

1

View

CLAIM CONSTRUCTION ANSWERING BRIEF re 69 Claim Construction Opening Brief filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Exhibits H-I)(Noreika, Maryellen) (Entered: 02/23/2017)

2017-02-23

1

View

Joint Letter to Chief Judge Leonard P. Stark from Anne Shea Gaza regarding request for a Discovery Teleconference. (Gaza, Anne) (Entered: 02/23/2017)

2017-02-23

1

View

AMENDED DOCUMENT by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. Amendment to 62 Claim Construction Chart -- Amended Joint Claim Construction Chart. (Attachments: # 1 Exhibit 68 - 71)(Noreika, Maryellen) (Entered: 02/24/2017)

2017-02-24

1

View

NOTICE OF SERVICE of Amneal's Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents and Things filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 03/01/2017)

2017-03-01

1

View

NOTICE OF SERVICE of Defendants' Second Set of Requests for Production of Documents and Things (Nos. 35-48) to Plaintiffs filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 03/02/2017)

2017-03-02

1

View

ORAL ORDER: IT IS HEREBY ORDERED that: (i) the parties are allocated 1.5 hours each for their presentations at the hearing on March 10; (ii) the hearing will include argument on claim construction and on the pending discovery dispute (see D.I. 76); and (iii) letters relating to the discovery dispute shall be filed on March 6 and 8. ORDERED by Judge Leonard P. Stark on 3/3/17. (ntl) (Entered: 03/03/2017)

2017-03-03

1

View

Order

2017-03-03

1

No Actions

Letter to The Honorable Leonard P. Stark from Anne Shea Gaza regarding Discovery Dispute - re 80 Order,. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Gaza, Anne) (Entered: 03/06/2017)

2017-03-06

1

View

[SEALED] Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding discovery dispute - re 81 Letter. (Attachments: # 1 Exhibits A-H)(Noreika, Maryellen) (Entered: 03/08/2017)

2017-03-08

1

View

Minute Entry for proceedings held before Judge Leonard P. Stark - Markman Hearing held on 3/10/2017. (Court Reporter B. Gaffigan.) (ntl)

2017-03-10

1

No Actions

Markman Hearing

2017-03-10

1

No Actions

REDACTED VERSION of 82 Letter by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Exhibit A - H)(Noreika, Maryellen) (Entered: 03/15/2017)

2017-03-15

1

View

NOTICE OF SERVICE of Defendants' First Set of Interrogatories (Nos. 1 19) filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 03/20/2017)

2017-03-20

1

View

Pro Hac Vice Attorney Vanessa Y. Yen and Evan D. Diamond for Galderma Laboratories L.P., for Nestle Skin Health S.A., and for TCD Royalty Sub LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)

2017-03-24

1

No Actions

Pro Hac Vice Attorney Gerald J. Flattmann, Jr for Galderma Laboratories L.P., for Nestle Skin Health S.A., and for TCD Royalty Sub LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)

2017-03-24

1

No Actions

Add Attorneys - PHV only

2017-03-24

1

No Actions

Add Attorneys - PHV only

2017-03-24

1

No Actions

Official Transcript of Claim Construction and Discovery Hearing held on March 10, 2017 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 4/21/2017. Redacted Transcript Deadline set for 5/1/2017. Release of Transcript Restriction set for 6/29/2017. (bpg) (Entered: 03/31/2017)

2017-03-31

1

View

NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Second Set of Requests for Production of Documents and Things (Nos. 35-48) filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 03/31/2017)

2017-03-31

1

View

STIPULATION TO EXTEND TIME for various dates in the scheduling order to various dates - see Stipulation for details - filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 04/03/2017)

2017-04-03

1

View

SO ORDERED, re 87 STIPULATION TO EXTEND TIME for various dates in the scheduling order to various dates - see Stipulation for details filed by Galderma Laboratories L.P., TCD Royalty Sub LLC, Nestle Skin Health S.A. Signed by Judge Leonard P. Stark on 4/5/17. (ntl)

2017-04-05

1

No Actions

SO ORDERED

2017-04-05

1

No Actions

NOTICE of Subpoena to Arash Raoufinia by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC (Attachments: # 1 Subpoena to Arash Raoufinia)(Wilson, Samantha) (Entered: 04/11/2017)

2017-04-11

1

View

NOTICE of Subpoena to Niraj Shah by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC (Attachments: # 1 Subpoena to Niraj Shah)(Wilson, Samantha) (Entered: 04/11/2017)

2017-04-11

1

View

NOTICE of Subpoena of Robert A. Ashley by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC (Attachments: # 1 Subpoena to Robert A. Ashley)(Wilson, Samantha) (Entered: 04/11/2017)

2017-04-11

1

View

NOTICE of Subpoena of Rong-Kun (Richard) Chang by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC (Attachments: # 1 Subpoena to Rong-Kun (Richard) Chang)(Wilson, Samantha) (Entered: 04/11/2017)

2017-04-11

1

View

[SEALED] NOTICE to Take Deposition of Galderma Laboratories, L.P. Pursuant to Fed.R.Civ.P. 30(b)(6) on May 8, 2017 filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 04/12/2017)

2017-04-12

1

View

NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Set of Interrogatories to Plaintiffs filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 04/17/2017)

2017-04-17

1

View

NOTICE requesting Clerk to remove Andrew T. Kessel as co-counsel. Reason for request: no longer associated with Paul Hastings. (Noreika, Maryellen) (Entered: 04/18/2017)

2017-04-18

1

View

REDACTED VERSION of 92 Notice to Take Deposition by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 04/19/2017)

2017-04-19

1

View

[SEALED] NOTICE to Take Deposition of Defendants Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Pursuant to Fed. R. Civ. P. 30(b)(6) on May 23, 2017 filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 04/20/2017)

2017-04-20

1

View

NOTICE OF SERVICE of Defendants' First Set of Requests for Admission (Nos. 1-19) filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 04/21/2017)

2017-04-21

1

View

NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Amneal Pharmaceuticals LLC, et al. (Nos. 1-4) filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 04/21/2017)

2017-04-21

1

View

NOTICE of Subpoena of Irving Feit by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC (Attachments: # 1 Subpoena to Irving Feit)(Wilson, Samantha) (Entered: 04/24/2017)

2017-04-24

1

View

NOTICE of Subpoena of M. Elisa Lane by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC (Attachments: # 1 Subpoena to M. Elisa Lane)(Wilson, Samantha) (Entered: 04/24/2017)

2017-04-24

1

View

NOTICE of Subpoena of Stephen Maebius by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC (Attachments: # 1 Subpoena of Stephen Maebius)(Wilson, Samantha) (Entered: 04/24/2017)

2017-04-24

1

View

NOTICE of Subpoena of Vasant Manna by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC (Attachments: # 1 Subpoena of Vasant Manna)(Wilson, Samantha) (Entered: 04/24/2017)

2017-04-24

1

View

NOTICE of Subpoena of Susan Sipos by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC (Attachments: # 1 Subpoena of Susan Sipos)(Wilson, Samantha) (Entered: 04/24/2017)

2017-04-24

1

View

NOTICE of Subpoena of Sunit Talapatra by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC (Attachments: # 1 Subpoena of Sunit Talapatra)(Wilson, Samantha) (Entered: 04/24/2017)

2017-04-24

1

View

NOTICE of Subpoena of Klaus Theobald by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC (Attachments: # 1 Subpoena of Klaus Theobald)(Wilson, Samantha) (Entered: 04/24/2017)

2017-04-24

1

View

NOTICE to Take Deposition of Rashmi Singh on May 19, 2017 filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 04/24/2017)

2017-04-24

1

View

NOTICE to Take Deposition of Rajesh Patel on May 24, 2017 filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 04/25/2017)

2017-04-25

1

View

NOTICE to Take Deposition of Jatin Gajjar on May 25, 2017 filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 04/25/2017)

2017-04-25

1

View

NOTICE to Take Deposition of Mayank Shrivastava on May 30, 2017 filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 04/25/2017)

2017-04-25

1

View

NOTICE to Take Deposition of Candis Edwards on May 31, 2017 filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 04/25/2017)

2017-04-25

1

View

NOTICE to Take Deposition of Priyanka Pawar on June 1, 2017 filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 04/25/2017)

2017-04-25

1

View

NOTICE to Take Deposition of Shilpa Patel on June 2, 2017 filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 04/25/2017)

2017-04-25

1

View

NOTICE to Take Deposition of Arlin Frias on June 5, 2017 filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 04/25/2017)

2017-04-25

1

View

NOTICE to Take Deposition of Paresh Malviya on June 6, 2017 filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 04/25/2017)

2017-04-25

1

View

NOTICE to Take Deposition of Narasimhan Mani on June 7, 2017 filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 04/25/2017)

2017-04-25

1

View

NOTICE to Take Deposition of Jigesh Shah on June 8, 2017 filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 04/25/2017)

2017-04-25

1

View

Amended NOTICE of Subpoena of Klaus Theobald by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC (Attachments: # 1 Subpoena of Klaus Theobald)(Wilson, Samantha) (Entered: 04/26/2017)

2017-04-26

1

View

[SEALED] NOTICE to Take Deposition of Nestle Skin Health S.A. Pursuant to Fed. R. Civ. P. 30(b)(6) on May 16, 2017 filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 04/26/2017)

2017-04-26

1

View

[SEALED] NOTICE to Take Deposition of TCD Royalty Sub LLC Pursuant to Fed. R. Civ. P. 30(b)(6) on May 17, 2017 filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 04/26/2017)

2017-04-26

1

View

Amended NOTICE of Subpoena of Irving Feit by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC (Attachments: # 1 Subpoena of Irving Feit)(Wilson, Samantha) (Entered: 04/27/2017)

2017-04-27

1

View

Amended NOTICE of Subpoena of M. Elisa Lane by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC (Attachments: # 1 Subpoena of M. Elisa Lane)(Wilson, Samantha) (Entered: 04/27/2017)

2017-04-27

1

View

REDACTED VERSION of 96 Notice to Take Deposition, by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 04/27/2017)

2017-04-27

1

View

NOTICE OF SERVICE of 1) Robert A. Ashley's Objections and Responses to Amneal's Subpoena for Testimony and the Production of Documents; and 2) Rong-Kun Chang's Objections and Responses to Amneal's Subpoena for Testimony and the Production of Documents filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 04/27/2017)

2017-04-27

1

View

NOTICE OF SERVICE of (1) Arash Raoufinia's Objections and Responses to Amneal's Subpoena for Testimony and the Production of Documents and (2) Niraj Shah's Objections and Responses to Amneal's Subpeona for Testimony and the Production of Documents filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 04/28/2017)

2017-04-28

1

View

Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding to request the scheduling of a discovery teleconference. (Noreika, Maryellen) (Entered: 04/28/2017)

2017-04-28

1

View

REDACTED VERSION of 118 Notice to Take Deposition of NESTL SKIN HEALTH S.A. PURSUANT TO FED. R. CIV. P. 30(b)(6) by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 05/03/2017)

2017-05-03

1

View

REDACTED VERSION of 119 Notice to Take Deposition of TCD Royalty Sub LLC Pursuant to Fed. R. Civ. P. 30(b)(6) by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 05/03/2017)

2017-05-03

1

View

NOTICE OF SERVICE of Galderma's Objections and Responses to Amneal's Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 05/08/2017)

2017-05-08

1

View

MEMORANDUM OPINION re claim construction. Signed by Judge Leonard P. Stark on 5/9/17. (ntl)

2017-05-09

1

Download

ORDER re 129 Memorandum Opinion regarding claim construction. Signed by Judge Leonard P. Stark on 5/9/17. (ntl) (Entered: 05/09/2017)

2017-05-09

1

View

NOTICE OF SERVICE of Plaintiffs' Requests for Admission filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 05/09/2017)

2017-05-09

1

View

NOTICE OF SERVICE of Susan Sipo's Objections and Responses to Amneal's Subpoena for Testimony and the Production of Documents filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 05/10/2017)

2017-05-10

1

View

NOTICE OF SERVICE of Klaus Theobald's Objections and Responses to Amneal's Subpoena for Testimony and the Production of Documents filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 05/11/2017)

2017-05-11

1

View

NOTICE OF SERVICE of Amneal's Objections and Responses to Plaintiffs' Notice of Deposition of Amneal Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 05/11/2017)

2017-05-11

1

View

NOTICE OF SERVICE of (1) NSH's Objections and Responses to Amneal's Notice of Deposition Pursuant to Fed. R. Cov. P. 30(b)(6) and (2) TCD's Objections and Responses to Amneal's Notice of Deposition Pursuant to Fed. R. Cov. P. 30(b)(6) filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 05/12/2017)

2017-05-12

1

View

ORAL ORDER: A teleconference is scheduled for Wednesday, 9/13/2017 at 9:30 A.M. Eastern time to be initiated by counsel for the plaintiff. The purpose is to discuss the status of the case and it's affect on mediation. Signed by Judge Mary Pat Thynge on 5/15/17. (kjk) (Entered: 05/15/2017)

2017-05-15

1

View

NOTICE OF SERVICE of Irving Feit's Objections and Responses to Amneal's Subpoena for Testimony and the Production of Documents filed by Irving Feit.(Blumenfeld, Jack) (Entered: 05/15/2017)

2017-05-15

1

View

Oral Order

2017-05-15

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Eimeric Reig-Plessis - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 05/16/2017)

2017-05-16

1

View

ORAL ORDER: After having been advised by Plaintiff(s) and Defendant(s) of their inability to resolve a discovery matter, IT IS HEREBY ORDERED that a teleconference is scheduled for May 31, 2017 at 10:15 a.m. Counsel for the party seeking relief shall initiate the teleconference call to 302-573-4571. IT IS FURTHER ORDERED that not later than May 22, 2017, any party seeking relief shall file with the Court a letter, not to exceed three (3) pages, outlining the issues in dispute and its position on those issues. Not later than May 24, 2017, any party opposing the application for relief may file a letter, not to exceed three (3) pages, outlining that party's reasons for its opposition. Each party shall submit to the Court two (2) courtesy copies of its discovery letter and any attachments. Should the Court find further briefing necessary upon conclusion of the telephone conference, the Court will order it. Alternatively, the Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Leonard P. Stark on 5/17/17. (ntl) (Entered: 05/17/2017)

2017-05-17

1

View

SO ORDERED

2017-05-17

1

No Actions

Order Setting Teleconference

2017-05-17

1

No Actions

SO ORDERED, re 138 MOTION for Pro Hac Vice Appearance of Attorney Eimeric Reig-Plessis filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 5/17/17. (ntl)

2017-05-17

1

No Actions

NOTICE of of Subpoena to Lawrence Feldman by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC (Attachments: # 1 Subpoena to Lawrence Feldman)(Wilson, Samantha) (Entered: 05/19/2017)

2017-05-19

1

View

Amended NOTICE of Subpoena to Lawrence Feldman by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC (Attachments: # 1 Subpoena to Lawrence R. Feldman)(Wilson, Samantha) (Entered: 05/22/2017)

2017-05-22

1

View

NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Set of Requests for Admission to Plaintiffs (Nos. 1-19) filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 05/22/2017)

2017-05-22

1

View

[SEALED] Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding Plaintiffs' Opening Letter to the Court pursuant to the May 17, 2017 Order - re 139 Order Setting Teleconference,,,,. (Noreika, Maryellen) (Entered: 05/22/2017)

2017-05-22

1

View

NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-14) filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 05/22/2017)

2017-05-22

1

View

[SEALED] EXHIBIT re 143 Letter to the Court pursuant to the Court's May 17, 2017 Order by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Exhibits 1-12 (Part 1 of 9), # 2 Exhibits 1-12 (Part 2 of 9), # 3 Exhibits 1-12 (Part 3 of 9), # 4 Exhibits 1-12 (Part 4 of 9), # 5 Exhibits 1-12 (Part 5 of 9), # 6 Exhibits 1-12 (Part 6 of 9), # 7 Exhibits 1-12 (Part 7 of 9), # 8 Exhibits 1-12 (Part 8 of 9), # 9 Exhibits 1-12 (Part 9 of 9))(Noreika, Maryellen) (Entered: 05/22/2017)

2017-05-22

1

View

[SEALED] Letter to The Honorable Leonard P. Stark from Anne Shea Gaza regarding Defendants' Responsive Letter to The Court Pursuant to the Court's May 17, 2017 Order (D..I. 139) - re 143 Letter. (Attachments: # 1 Exhibit A)(Gaza, Anne) (Entered: 05/24/2017)

2017-05-24

1

View

ORAL ORDER: Having reviewed the submissions relating to a discovery dispute (D.I. 143, 145, 146), IT IS HEREBY ORDERED that Plaintiffs' and Non-Parties' request for an order to prevent depositions of the Non-Party inventors is DENIED. Defendants seek to depose the inventors to obtain relevant, non-duplicative evidence, with respect to Plaintiffs' previously untried theory of infringement under the doctrine of equivalents and with respect to four new patents. Based on Defendants' representation to avoid cumulative or harassing examination, and their willingness to schedule the depositions at a time and location convention to the deponents, the Court does not find that the burden imposed is unfair to the deponents nor disproportionate to the needs of the case. IT IS FURTHER ORDERED that the teleconference scheduled for tomorrow is CANCELLED. ORDERED by Judge Leonard P. Stark on 5/30/17. (ntl) (Entered: 05/30/2017)

2017-05-30

1

View

STIPULATION and [Proposed] Order Regarding the Parties' Use of Testimony from Dr. Lawrence R. Feldman by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 05/30/2017)

2017-05-30

1

View

Order Cancelling Deadline

2017-05-30

1

No Actions

NOTICE OF SERVICE of Galderma's Objections and Responses to Amneal's May 24, 2017 Revised Notice of Deposition Topic Nos. 7, 12, 13, 16, and 18 Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 05/31/2017)

2017-05-31

1

View

REDACTED VERSION of 143 Letter by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 05/31/2017)

2017-05-31

1

View

REDACTED VERSION of 145 Exhibit to a Document,, by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 05/31/2017)

2017-05-31

1

View

REDACTED VERSION of 146 Letter, by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Gaza, Anne) (Entered: 06/01/2017)

2017-06-01

1

View

SO ORDERED, re 148 STIPULATION and Order Regarding the Parties' Use of Testimony from Dr. Lawrence R. Feldman. Signed by Judge Leonard P. Stark on 6/1/17. (ntl)

2017-06-01

1

No Actions

SO ORDERED

2017-06-01

1

No Actions

Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding the parties' request for discovery teleconference. (Noreika, Maryellen) (Entered: 06/02/2017)

2017-06-02

1

View

NOTICE OF SERVICE of 1) Amneal's Objections and Responses to Plaintiffs' First Set of Requests for Admission; and 2) Defendants' Amended Initial Invalidity Contentions filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 06/09/2017)

2017-06-09

1

View

ORAL ORDER: After having been advised by Plaintiff(s) and Defendant(s) of their inability to resolve a discovery matter, IT IS HEREBY ORDERED that a teleconference is scheduled for July 19, 2017 at 11:30 a.m. Counsel for the party seeking relief shall initiate the teleconference call to 302-573-4571. IT IS FURTHER ORDERED that not later than July 10, 2017, any party seeking relief shall file with the Court a letter, not to exceed three (3) pages, outlining the issues in dispute and its position on those issues. Not later than July 12, 2017, any party opposing the application for relief may file a letter, not to exceed three (3) pages, outlining that party's reasons for its opposition. Each party shall submit to the Court two (2) courtesy copies of its discovery letter and any attachments. Should the Court find further briefing necessary upon conclusion of the telephone conference, the Court will order it. Alternatively, the Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Leonard P. Stark on 7/3/17. (etg) (Entered: 07/03/2017)

2017-07-03

1

View

~Util - Set Hearings AND Oral Order

2017-07-03

1

No Actions

NOTICE OF SERVICE of Defendants' Final Supplementation of Invalidity Contentions filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 07/06/2017)

2017-07-06

1

View

[SEALED] Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding discovery dispute - re 155 Oral Order,,,,, Set Hearings,,,,. (Attachments: # 1 Exhibits A-W)(Noreika, Maryellen) (Entered: 07/10/2017)

2017-07-10

1

View

[SEALED] Letter to The Honorable Leonard P. Stark from Anne Shea Gaza regarding Defendants' Responsive Letter to the Court Pursuant to the Court's July 3, 2017 Order (D.I. 155) - re 155 Oral Order,,,,, Set Hearings,,,,. (Attachments: # 1 Exhibit 1 - 8)(Gaza, Anne) (Entered: 07/12/2017)

2017-07-12

1

View

ORAL ORDER: IT IS HEREBY ORDERED that the discovery teleconference scheduled for July 19 will begin at 9:00 a.m. ORDERED by Judge Leonard P. Stark on 7/17/17. (ntl) (Entered: 07/17/2017)

2017-07-17

1

View

Order Setting Teleconference

2017-07-17

1

No Actions

ORAL ORDER: IT IS HEREBY ORDERED that the discovery teleconference scheduled for July 19 will begin at 9:15 a.m. ORDERED by Judge Leonard P. Stark on 7/18/17. (ntl) (Entered: 07/18/2017)

2017-07-18

1

View

REDACTED VERSION of 157 Letter to The Honorable Leonard P. Stark regarding discovery dispute by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Exhibits A-W)(Blumenfeld, Jack) (Entered: 07/18/2017)

2017-07-18

1

View

Order Setting Teleconference

2017-07-18

1

No Actions

REDACTED VERSION of 158 Letter, Letter to The Honorable Leonard P. Stark from Anne Shea Gaza regarding Defendants' Responsive Letter to the Court Pursuant to the Court's July 3, 2017 Order (D.I. 155) by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 07/19/2017)

2017-07-19

1

View

Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 7/19/2017. (Court Reporter B. Gaffigan.) (ntl)

2017-07-19

1

No Actions

Telephone Conference

2017-07-19

1

No Actions

STIPULATION regarding Depositions by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 08/15/2017)

2017-08-15

1

View

STIPULATION TO EXTEND TIME of Certain Scheduling Order Deadlines to see Stipulation - filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 08/17/2017)

2017-08-17

1

View

SO ORDERED

2017-08-18

1

No Actions

SO ORDERED, re 164 STIPULATION TO EXTEND TIME of Certain Scheduling Order Deadlines; 163 Stipulation and Order regarding depositions. Signed by Judge Leonard P. Stark on 8/18/17. (ntl)

2017-08-18

1

No Actions

Official Transcript of Telephone Conference held on July 19, 2017 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/12/2017. Redacted Transcript Deadline set for 9/22/2017. Release of Transcript Restriction set for 11/20/2017. (bpg) (Entered: 08/22/2017)

2017-08-22

1

View

NOTICE OF SERVICE of Plaintiffs' First Supplemental Initial Infringement Claim Chart filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 08/25/2017)

2017-08-25

1

View

ORAL ORDER Setting Teleconference: The teleconference set for 9/13/2017 at 9:30 AM Eastern Time before Judge Mary Pat Thynge shall now take place at 10:30 AM Eastern Time. Plaintiff's counsel to initiate the call. Ordered by Judge Mary Pat Thynge on 9/8/17. (cak) Modified on 9/8/2017 (cak). (Entered: 09/08/2017)

2017-09-08

1

View

CORRECTING ENTRY: DI 167 was corrected to reflect that the original teleconference set for 9:30 AM Eastern Time will now take place at 10:30 AM Eastern Time (cak)

2017-09-08

1

No Actions

Order Setting Teleconference

2017-09-08

1

No Actions

- CORRECTING ENTRY

2017-09-08

1

No Actions

Pro Hac Vice Attorney Eimeric Reig-Plessis for Amneal Pharmaceuticals Co. (I) Pvt. Ltd.,Eimeric Reig-Plessis for Amneal Pharmaceuticals LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)

2017-09-11

1

No Actions

Add Attorneys - PHV only

2017-09-11

1

No Actions

NOTICE OF SERVICE of Opening Expert Reports of 1) Barry Kreiswirth, Ph.D.; 2) Monte Meltzer, M.D.; and 3) Edmund Elder, Ph.D. filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 09/12/2017)

2017-09-12

1

View

MOTION for Pro Hac Vice Appearance of Attorney Leo C. DeSesso - filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 09/12/2017)

2017-09-12

1

View

NOTICE OF SERVICE of (1) Opening Expert Report of Dr. George G. Zhanel; (2) Expert Report of Edward M. Rudnic, Ph.D. Regarding Amneal's Infringement of U.S. Patent Nos. 7,749,532; 8,206,740; 8,394,405; 8,394,406; 8,470,364; and 8,709,478; and (3) Expert Report of Guy F. Webster, M.D., Ph.D. filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 09/13/2017)

2017-09-13

1

View

ORAL ORDER Setting Teleconference: Defense counsel to initiate the call. A Telephone Conference is set for 1/8/2018 at 10:30 AM Eastern Time before Judge Mary Pat Thynge. Signed by Judge Mary Pat Thynge on 9/13/17. (cak) (Entered: 09/13/2017)

2017-09-13

1

View

Order Setting Teleconference

2017-09-13

1

No Actions

MOTION to Strike Plaintiffs' Supplemental Infringement Claim Chart - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Attachments: # 1 Defendants' D. Del. LR 7.1.1 Certification, # 2 Text of Proposed Order, # 3 Certificate of Service)(Gaza, Anne) (Entered: 09/14/2017)

2017-09-14

1

View

[SEALED] Letter to Chief Judge Leonard P. Stark from Anne Shea Gaza, Esq. regarding Defendants' Motion to Strike Plaintiffs' Supplemental Infringement Claim Chart - re 172 MOTION to Strike Plaintiffs' Supplemental Infringement Claim Chart. (Attachments: # 1 Exhibits 1 through 4, # 2 Certificate of Service)(Gaza, Anne) (Entered: 09/14/2017)

2017-09-14

1

View

SO ORDERED, re 169 MOTION for Pro Hac Vice Appearance of Attorney Leo C. DeSesso filed by Galderma Laboratories L.P., TCD Royalty Sub LLC, Nestle Skin Health S.A. Signed by Judge Leonard P. Stark on 9/14/17. (ntl)

2017-09-14

1

No Actions

SO ORDERED

2017-09-14

1

No Actions

REDACTED VERSION of 173 Letter, in Support of Motion to Strike Plaintiffs' Supplemental Infringement Claim Chart by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 09/21/2017)

2017-09-21

1

View

[SEALED] Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding Plaintiffs' Response to Amneal's Motion to Strike Plaintiffs' Supplemental Infringement Claim Chart. (Attachments: # 1 Exhibits A-G)(Noreika, Maryellen) (Entered: 09/21/2017)

2017-09-21

1

View

[SEALED] Letter to The Honorable Leonard P. Stark from Anne Shea Gaza, Esq. regarding Reply in Support of Defendant's Motion to Strike Plaintiffs' Supplemental Infringement Claim Chart - re 172 MOTION to Strike Plaintiffs' Supplemental Infringement Claim Chart. (Attachments: # 1 [SEALED] Exhibits 5 through 9 to Letter)(Gaza, Anne) (Entered: 09/25/2017)

2017-09-25

1

View

Letter to The Honorable Leonard P. Stark from Anne Shea Gaza, Esq. regarding a request for a teleconference - re 172 MOTION to Strike Plaintiffs' Supplemental Infringement Claim Chart. (Gaza, Anne) (Entered: 09/25/2017)

2017-09-25

1

View

REDACTED VERSION of 176 Letter, to the Court In Support of Motion to Strike Plaintiffs' Supplemental Claim Chart by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 10/02/2017)

2017-10-02

1

View

REDACTED VERSION of 175 Letter, by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Exhibit A - G)(Noreika, Maryellen) (Entered: 10/03/2017)

2017-10-03

1

View

NOTICE OF SERVICE of (1) Rebuttal Expert Report of Dr. George G. Zhanel; (2) Rebuttal Expert Report of Edward M. Rudnic, Ph.D.; (3) Rebuttal Expert Report of Guy F. Webster, M.D., Ph.D.; and (4) Expert Report of Henry G. Grabowski, Ph.D. filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 10/17/2017)

2017-10-17

1

View

NOTICE OF SERVICE of Rebuttal Expert Reports of (1) Edmund Elder, Ph.D.; (2) Monte Meltzer, M.D.; and (3) Barry N. Kreiswirth, Ph.D. filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 10/18/2017)

2017-10-18

1

View

NOTICE requesting Clerk to remove Joanna F. Cornwell as co-counsel.. (Wilson, Samantha) (Entered: 10/25/2017)

2017-10-25

1

View

ORAL ORDER: After having been advised by Plaintiff(s) and Defendant(s) of their inability to resolve a discovery matter, IT IS HEREBY ORDERED that a teleconference is scheduled for November 30, 2017 at 4:15 p.m. Counsel for the party seeking relief shall initiate the teleconference call to 302-573-4571. IT IS FURTHER ORDERED that not later than November 17, 2017, any party seeking relief shall file with the Court a letter, not to exceed three (3) pages, outlining the issues in dispute and its position on those issues. Not later than November 21, 2017, any party opposing the application for relief may file a letter, not to exceed three (3) pages, outlining that party's reasons for its opposition. Each party shall submit to the Court two (2) courtesy copies of its discovery letter and any attachments. Should the Court find further briefing necessary upon conclusion of the telephone conference, the Court will order it. Alternatively, the Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Leonard P. Stark on 10/26/17. (ntl) (Entered: 10/26/2017)

2017-10-26

1

View

Order Setting Teleconference

2017-10-26

1

No Actions

Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding request for discovery teleconference. (Noreika, Maryellen) (Entered: 11/07/2017)

2017-11-07

1

View

Pro Hac Vice Attorney Lucas L. Kressel for Galderma Laboratories L.P., Nestle Skin Health S.A., and TCD Royalty Sub LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:16-cv-01003-LPS, 1:16-cv-00207-LPS(ceg)

2017-11-09

1

No Actions

Add Attorneys - PHV only

2017-11-09

1

No Actions

STIPULATION TO EXTEND TIME for Defendants to serve their anticipated reply expert report of Ms. Catharine Lawton to November 17, 2017 - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 11/10/2017)

2017-11-10

1

View

STIPULATION TO EXTEND TIME for the parties to serve their reply expert reports (excluding the Cathy Lawton report) to November 14, 2017 - filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 11/13/2017)

2017-11-13

1

View

SO ORDERED, re 185 STIPULATION TO EXTEND TIME for Defendants to serve their anticipated reply expert report of Ms. Catharine Lawton to November 17, 2017 filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 11/13/17. (ntl)

2017-11-13

1

No Actions

SO ORDERED

2017-11-13

1

No Actions

NOTICE OF SERVICE of (1) Reply Expert Report of Dr. George G. Zhanel; (2) Reply Expert Report of Guy F. Webster, M.D., Ph.D.; and (3) Reply Expert Report of Edward M. Rudnic, Ph.D. filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 11/15/2017)

2017-11-15

1

View

ORAL ORDER: IT IS HEREBY ORDERED that during the teleconference on November 30, the Court will hear argument on the motion to strike (D.I. 172) and the discovery dispute (D.I. 184). Letter submissions on the discovery dispute are due on November 17 and November 21. No further submissions are needed on the motion to strike. ORDERED by Judge Leonard P. Stark on 11/15/17. (ntl) (Entered: 11/15/2017)

2017-11-15

1

View

SO ORDERED, re 186 STIPULATION TO EXTEND TIME for the parties to serve their reply expert reports (excluding the Cathy Lawton report) to November 14, 2017 filed by Galderma Laboratories L.P., TCD Royalty Sub LLC, Nestle Skin Health S.A. Signed by Judge Leonard P. Stark on 11/15/17. (ntl)

2017-11-15

1

No Actions

SO ORDERED

2017-11-15

1

No Actions

Order

2017-11-15

1

No Actions

NOTICE OF SERVICE of (1) Reply Expert Report of Edmund Elder, Ph.D.; (2) Reply Expert Report of Monte Meltzer, M.D.; and (3) Reply Expert Report of Barry N. Kreiswirth, Ph.D. filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 11/16/2017)

2017-11-16

1

View

[SEALED] Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding Court's November 15, 2017 Order (D.I. 188) - re 188 Order,. (Attachments: # 1 Exhibits A-E)(Noreika, Maryellen) (Entered: 11/17/2017)

2017-11-17

1

View

[SEALED] Letter to The Honorable Leonard P. Stark from Anne Shea Gaza regarding Response to Plaintiffs' November 17, 2017 Letter - re 188 Order, 190 Letter. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Gaza, Anne) (Entered: 11/21/2017)

2017-11-21

1

View

NOTICE to Take Deposition of Dr. Edward M. Rudnic on December 5, 2017 filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 11/22/2017)

2017-11-22

1

View

NOTICE OF SERVICE of Rebuttal Expert Report of Catharine M. Lawton filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 11/22/2017)

2017-11-22

1

View

NOTICE to Take Deposition of Edmund J. Elder, Jr., Ph.D. on November 30, 2017 filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 11/27/2017)

2017-11-27

1

View

NOTICE to Take Deposition of Barry N. Kreiswirth, Ph.D. on December 15, 2017 filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 11/27/2017)

2017-11-27

1

View

NOTICE to Take Deposition of Catherine M. Lawton on December 19, 2017 filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 11/27/2017)

2017-11-27

1

View

NOTICE to Take Deposition of Monte S. Meltzer, Ph.D. on December 19, 2017 filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 11/27/2017)

2017-11-27

1

View

NOTICE to Take Deposition of Dr. Guy F. Webster on December 8, 2017 filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 11/27/2017)

2017-11-27

1

View

NOTICE to Take Deposition of Dr. Henry G. Grabowski on December 13, 2017 filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 11/27/2017)

2017-11-27

1

View

NOTICE to Take Deposition of Dr. George G. Zhanel on December 13, 2017 filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 11/27/2017)

2017-11-27

1

View

REDACTED VERSION of 190 Letter by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Exhibit A - E)(Noreika, Maryellen) (Entered: 11/28/2017)

2017-11-28

1

View

REDACTED VERSION of 191 Letter by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Attachments: # 1 Exhibit 1 and 2 REDACTED)(Gaza, Anne) (Entered: 11/28/2017)

2017-11-28

1

View

ORAL ORDER: Having reviewed the parties' submissions (see D.I. 173, 175, 176, 190, 191), IT IS HEREBY ORDERED that: (1) Defendants' motion to strike Plaintiffs' supplemental infringement contentions (D.I. 172), which asserted literal infringement - for the first time - two months after the deadline for supplementing contentions, nearly three months after the close of fact discovery, and around five months after it appears Plaintiffs had received in discovery the dissolution data (see, e.g., D.I. 176 Ex. 5) purportedly critical to their belated theory, is GRANTED; the Pennypack factors support this conclusion, notwithstanding the importance of the evidence being stricken and the lack of indications of bad faith, as Defendants were surprised, are prejudiced (in ways articulated in their letters), Plaintiffs' explanation for the timing of its new theory is unpersuasive (and they do not attempt to explain why they provided Defendants' no hint they might eventually assert literal infringement), and no other adequate remedy is possible without disrupting the trial scheduled for February 2018; Plaintiffs' conduct was neither substantially justified nor harmless; (2) Plaintiffs' request that the Court strike Defendants' written description defense is DENIED AS MOOT, as Defendants have represented they will withdraw this defense if the Court strikes literal infringement, as the Court has done; (3) Plaintiffs' request that the Court find Defendants have waived attorney-client privilege, and require a privilege log and in camera review of documents, largely based on Plaintiffs' unpersuasive interpretation of a small portion of Defendants' motion to strike, is DENIED, as it does not appear to the Court that Defendants have injected privileged communications into the case; and (4) the teleconference scheduled for tomorrow, November 30, is CANCELLED. ORDERED by Judge Leonard P. Stark on 11/29/17. (ntl) (Entered: 11/29/2017)

2017-11-29

1

View

Order AND Order Cancelling Deadline

2017-11-29

1

No Actions

[SEALED] MOTION for Reconsideration re 203 Order,,,,,,,, Order Cancelling Deadline,,,,,,, - filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Exhibit A - I)(Noreika, Maryellen) (Entered: 12/11/2017)

2017-12-11

1

View

REDACTED VERSION of 204 MOTION for Reconsideration re 203 Order,,,,,,,, Order Cancelling Deadline,,,,,,, by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Exhibits A-I)(Noreika, Maryellen) (Entered: 12/20/2017)

2017-12-20

1

View

[SEALED] RESPONSE to Motion re 204 MOTION for Reconsideration re 203 Order,,,,,,,, Order Cancelling Deadline,,,,,,, filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Attachments: # 1 Exhibit 1)(Gaza, Anne) (Entered: 12/27/2017)

2017-12-27

1

View

STIPULATION and (Proposed) Order Regarding Schedule for Pretrial Exchanges by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 01/02/2018)

2018-01-02

1

View

REDACTED VERSION of 206 Response to Motion, for Reconsideration of the Court's November 29, 2017 Order Granting Amneal's Motion to Strike by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Gaza, Anne) (Entered: 01/03/2018)

2018-01-03

1

View

SO ORDERED

2018-01-05

1

No Actions

SO ORDERED, re 207 STIPULATION and Order Regarding Schedule for Pretrial Exchanges. Signed by Judge Leonard P. Stark on 1/5/18. (ntl)

2018-01-05

1

No Actions

STATEMENT re 204 MOTION for Reconsideration re 203 Order,,,,,,,, Order Cancelling Deadline,,,,,,, -- Plaintiffs' Supplemental Rule 7.1.1 Certification -- by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 01/09/2018)

2018-01-09

1

View

Joint Letter to The Honorable Leonard P. Stark from Anne Shea Gaza regarding the parties' request for a discovery teleconference. (Gaza, Anne) (Entered: 01/10/2018)

2018-01-10

1

View

MOTION for Pro Hac Vice Appearance of Attorney George C. Lombardi - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 01/12/2018)

2018-01-12

1

View

NOTICE OF SERVICE of Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Notice Pursuant to 35 U.S.C. § 282 filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 01/16/2018)

2018-01-16

1

View

SO ORDERED, re 211 MOTION for Pro Hac Vice Appearance of Attorney George C. Lombardi filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 1/17/18. (ntl)

2018-01-17

1

No Actions

SO ORDERED

2018-01-17

1

No Actions

MEMORANDUM ORDER DENYING re 204 MOTION for Reconsideration filed by Galderma Laboratories L.P., TCD Royalty Sub LLC, Nestle Skin Health S.A. Signed by Judge Leonard P. Stark on 1/22/18. (ntl)

2018-01-22

1

Download

ORAL ORDER: After having been advised by Plaintiff(s) and Defendant(s) of their inability to resolve a discovery matter, IT IS HEREBY ORDERED that a teleconference is scheduled for January 29, 2018 at 4:00 p.m. Counsel for the party seeking relief shall initiate the teleconference call to 302-573-4571. IT IS FURTHER ORDERED that not later than January 26, 2018 at 12:00 p.m., any party seeking relief shall file with the Court a letter, not to exceed three (3) pages, outlining the issues in dispute and its position on those issues. Not later than January 29, 2018 at 12:00 p.m., any party opposing the application for relief may file a letter, not to exceed three (3) pages, outlining that party's reasons for its opposition. Each party shall submit to the Court two (2) courtesy copies of its discovery letter and any attachments. Should the Court find further briefing necessary upon conclusion of the telephone conference, the Court will order it. Alternatively, the Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Leonard P. Stark on 1/25/18. (ntl) (Entered: 01/25/2018)

2018-01-25

1

View

[SEALED] Proposed Pretrial Order (Volume 1 of 2) (Exhibits 1-9) by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Exhibits 1-9)(Noreika, Maryellen) (Entered: 01/25/2018)

2018-01-25

1

View

[SEALED] Proposed Pretrial Order (Volume 2 of 2) (Exhibits 10-14) by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Exhibits 10-14)(Noreika, Maryellen) (Entered: 01/25/2018)

2018-01-25

1

View

Order Setting Teleconference

2018-01-25

1

No Actions

[SEALED] Letter to The Honorable Leonard P. Stark from Anne Shea Gaza regarding Defendants' Letter in Support of Their Request for Sanctions or Additional Depositions for Conduct at Expert Depositions. (Attachments: # 1 Exhibit 1 - 3)(Gaza, Anne) (Entered: 01/26/2018)

2018-01-26

1

View

Joint Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding Request for Discovery Teleconference. (Noreika, Maryellen) (Entered: 01/26/2018)

2018-01-26

1

View

[SEALED] Letter to The Honorable Leonard P. Stark from Jeremy A. Tigan regarding discovery dispute - re 217 Letter,. (Tigan, Jeremy) (Entered: 01/29/2018)

2018-01-29

1

View

MOTION for Pro Hac Vice Appearance of Attorney Ryan B. Hauer - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 01/29/2018)

2018-01-29

1

View

Minute Entry for proceedings held before Judge Leonard P. Stark - Teleconference held on 1/29/2018. (Court Reporter B. Gaffigan.) (ntl)

2018-01-29

1

No Actions

ORAL ORDER: IT IS HEREBY ORDERED that, for the reasons stated during the teleconference of January 29, (i) each side will be allocated thirteen (13) hours for its trial presentation; and (ii) trial will be held at all or some of the following times, provided one or both sides have time remaining: Feb. 12 (8:30-5:00), Feb. 13 (8:30-6:00), Feb. 14 (8:30-1:00), Feb. 15 (8:30-6:00), and Feb. 16 (8:30-5:00). ORDERED by Judge Leonard P. Stark on 1/30/18. (ntl) (Entered: 01/30/2018)

2018-01-30

1

View

ORAL ORDER: IT IS HEREBY ORDERED that a Teleconference is scheduled for February 1, 2018 at 1:30 PM. Counsel for Amneal shall initiate the call to (302) 573-4571. The Pretrial Conference scheduled for February 2, 2018 is CANCELLED. ORDERED by Judge Leonard P. Stark on 1/30/18. (ntl) (Entered: 01/30/2018)

2018-01-30

1

View

SO ORDERED, re 220 MOTION for Pro Hac Vice Appearance of Attorney Ryan B. Hauer filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 1/30/18. (ntl)

2018-01-30

1

No Actions

1 - Terminate Hearings AND Order Setting Teleconference

2018-01-30

1

No Actions

Discovery Conference

2018-01-30

1

No Actions

SO ORDERED

2018-01-30

1

No Actions

Order

2018-01-30

1

No Actions

[SEALED] Transcript of Telephone Conference with some Pretrial Rulings held on January 29, 2018 before Chief Judge Leonard P. Stark. (bpg) (Entered: 02/01/2018)

2018-02-01

1

View

Letter to The Honorable Leonard P. Stark from Jeremy A. Tigan regarding focused set of asserted claims. (Tigan, Jeremy) (Entered: 02/01/2018)

2018-02-01

1

View

REDACTED VERSION of 215 Proposed Pretrial Order by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Exhibit 1 - 9)(Tigan, Jeremy) (Attachment 1 replaced on 3/12/2018) (ntl). (Entered: 02/01/2018)

2018-02-01

1

View

REDACTED VERSION of 216 Proposed Pretrial Order by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Exhibit 10 - 14)(Tigan, Jeremy) (Attachment 1 replaced on 3/12/2018) (ntl). (Entered: 02/01/2018)

2018-02-01

1

View

Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 2/1/2018. (Court Reporter B. Gaffigan.) (ntl)

2018-02-01

1

No Actions

Telephone Conference

2018-02-01

1

No Actions

REDACTED VERSION of 217 Letter, Defendants' Letter to the Court in Support of Their Request for Sanctions or Additional Depositions for Conduct at Expert Depositions by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Attachments: # 1 Exhibit 1-3)(Gaza, Anne) (Entered: 02/03/2018)

2018-02-03

1

View

NOTICE OF SERVICE of Declaration of Monte S. Meltzer, M.D. filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 02/07/2018)

2018-02-07

1

View

MOTION for Pro Hac Vice Appearance of Attorney Elizabeth E. Grden - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 02/07/2018)

2018-02-07

1

View

NOTICE to Take Deposition of Dr. Guy F. Webster on February 10, 2018 filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 02/08/2018)

2018-02-08

1

View

NOTICE to Take Deposition of Dr. Edward M. Rudnic on February 9, 2018 filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 02/08/2018)

2018-02-08

1

View

NOTICE of Intent to Request Redaction by Samantha G. Wilson re 223 Transcript (Wilson, Samantha) (Entered: 02/08/2018)

2018-02-08

1

View

MOTION for Pro Hac Vice Appearance of Attorney Kevin P. Broughel and Michael C. Whalen - filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 02/08/2018)

2018-02-08

1

View

Pro Hac Vice Attorney Ryan B. Hauer for Amneal Pharmaceuticals Co. (I) Pvt. Ltd.,Ryan B. Hauer for Amneal Pharmaceuticals LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

2018-02-08

1

No Actions

Add Attorneys - PHV only

2018-02-08

1

No Actions

SO ORDERED, re 229 MOTION for Pro Hac Vice Appearance of Attorney Elizabeth E. Grden filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd., 233 MOTION for Pro Hac Vice Appearance of Attorney Kevin P. Broughel and Michael C. Whalen filed by Galderma Laboratories L.P., TCD Royalty Sub LLC, Nestle Skin Health S.A. Signed by Judge Leonard P. Stark on 2/9/18. (ntl)

2018-02-09

1

No Actions

SO ORDERED

2018-02-09

1

No Actions

STIPULATION and (Proposed) Order Regarding Schedule for Pretrial Exchanges re 215 Proposed Pretrial Order by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 02/11/2018)

2018-02-11

1

View

Letter to The Honorable Leonard P. Stark from Anne Shea Gaza regarding the Deposition Testimony of Dr. Lawrence Feldman. (Gaza, Anne) (Entered: 02/12/2018)

2018-02-12

1

View

SO ORDERED, re 234 STIPULATION and (Proposed) Order Regarding Schedule for Pretrial Exchanges filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 2/12/18. (ntl)

2018-02-12

1

No Actions

Minute Entry for proceedings held before Judge Leonard P. Stark - Bench Trial held on 2/12/2018. (Court Reporter B. Gaffigan.) (ntl)

2018-02-12

1

No Actions

SO ORDERED

2018-02-12

1

No Actions

[SEALED] EXHIBIT re 235 Letter to the Honorable Leonard P. Stark regarding The Deposition Testimony of Dr. Lawrence Feldman by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Gaza, Anne) (Entered: 02/13/2018)

2018-02-13

1

View

Minute Entry for proceedings held before Judge Leonard P. Stark - Bench Trial held on 2/13/2018. (Court Reporter B. Gaffigan/V. Gunning.) (ntl)

2018-02-13

1

No Actions

Bench Trial - Begun

2018-02-13

1

No Actions

Minute Entry for proceedings held before Judge Leonard P. Stark - Bench Trial held on 2/14/2018. (Court Reporter B. Gaffigan/V. Gunning.) (ntl)

2018-02-14

1

No Actions

Bench Trial - Held

2018-02-14

1

No Actions

Minute Entry for proceedings held before Judge Leonard P. Stark - Bench Trial held on 2/15/2018. (Court Reporter B. Gaffigan/V. Gunning.) (ntl)

2018-02-15

1

No Actions

Bench Trial - Held

2018-02-15

1

No Actions

Minute Entry for proceedings held before Judge Leonard P. Stark - Bench Trial completed on 2/16/2018. (Court Reporter B. Gaffigan/V. Gunning.) (ntl)

2018-02-16

1

No Actions

Bench Trial - Completed

2018-02-16

1

No Actions

Bench Trial - Held

2018-02-16

1

No Actions

Letter to The Honorable Leonard P. Stark from Anne Shea Gaza regarding Volume E of the trial transcript. (Gaza, Anne) (Entered: 02/20/2018)

2018-02-20

1

View

REDACTED VERSION of 236 Exhibit to a Document re 235 Letter to the Honorable Leonard P. Stark regarding The Deposition Testimony of Dr. Lawrence Feldman by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 02/21/2018)

2018-02-21

1

View

MOTION to Redact 223 Transcript [Unopposed] - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Attachments: # 1 Exhibit A, # 2 Text of Proposed Order)(Wilson, Samantha) (Entered: 02/22/2018)

2018-02-22

1

View

[SEALED] EXHIBIT re 239 MOTION to Redact 223 Transcript [Unopposed] by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 02/22/2018)

2018-02-22

1

View

Official Transcript of Telephonic Pretrial Conference held on February 1, 2018 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 3/16/2018. Redacted Transcript Deadline set for 3/26/2018. Release of Transcript Restriction set for 5/24/2018. (bpg) (Entered: 02/23/2018)

2018-02-23

1

View

REDACTED VERSION of 240 Exhibit to a Document by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 03/01/2018)

2018-03-01

1

View

CORRECTING ENTRY: Corrected exhibits added to D.I. 225-226 per request of counsel. (ntl)

2018-03-12

1

No Actions

- CORRECTING ENTRY

2018-03-12

1

No Actions

ORDER re 239 MOTION to Redact 223 Transcript [Unopposed] filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 3/14/18. (ntl) (Entered: 03/15/2018)

2018-03-15

1

View

[SEALED] POST TRIAL BRIEF (Opening) by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Blumenfeld, Jack) (Entered: 03/16/2018)

2018-03-16

1

View

[SEALED] Proposed Findings of Fact by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Blumenfeld, Jack) (Main Document 245 replaced on 3/19/2018) (ntl). (Entered: 03/16/2018)

2018-03-16

1

View

[SEALED] POST TRIAL BRIEF by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Gaza, Anne) (Entered: 03/16/2018)

2018-03-16

1

View

[SEALED] Proposed Findings of Fact by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Gaza, Anne) (Entered: 03/16/2018)

2018-03-16

1

View

Letter to The Honorable Leonard P. Stark from Anne Shea Gaza regarding post-trial briefing - re 247 Proposed Findings of Fact, 246 POST Trial Brief. (Gaza, Anne) (Entered: 03/16/2018)

2018-03-16

1

View

CORRECTING ENTRY: Corrected document added to D.I. 245 per request of counsel. (ntl)

2018-03-19

1

No Actions

- CORRECTING ENTRY

2018-03-19

1

No Actions

NOTICE requesting Clerk to remove Chloe X. Jiang and Si (Annie) Chen as co-counsel. Reason for request: no longer associated with Paul Hastings. (Noreika, Maryellen) (Entered: 03/20/2018)

2018-03-20

1

View

REDACTED VERSION of 244 POST Trial Brief by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 03/23/2018)

2018-03-23

1

View

REDACTED VERSION of 245 Proposed Findings of Fact by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 03/23/2018)

2018-03-23

1

View

REDACTED VERSION of 246 POST Trial Brief by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 03/23/2018)

2018-03-23

1

View

REDACTED VERSION of 247 Proposed Findings of Fact by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 03/23/2018)

2018-03-23

1

View

Redaction of 223 Transcript. Transcript of Telephone Conference with some Pretrial Rulings held on January 29, 2018 before Chief Judge Leonard P. Stark.Court Reporter Brian P. Gaffigan, Phone No. (302) 573-6360. (bpg) (Entered: 03/26/2018)

2018-03-26

1

View

DECLARATION of Guy F. Webster, M.D., Ph.D., to Correct the Trial Transcript Record by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Exhibits A-B)(Noreika, Maryellen) (Entered: 04/02/2018)

2018-04-02

1

View

Official Transcript of Bench Trial - Volume A held on February 12, 2018 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone No. (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 4/24/2018. Redacted Transcript Deadline set for 5/4/2018. Release of Transcript Restriction set for 7/2/2018. (bpg) (Entered: 04/03/2018)

2018-04-03

1

View

[SEALED] Transcript of Bench Trial - Volume A held on February 12, 2018 before Chief Judge Leonard P. Stark. (bpg) (Entered: 04/03/2018)

2018-04-03

1

View

Official Transcript of Bench Trial - Volume B held on February 13, 2018 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone No. (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 4/24/2018. Redacted Transcript Deadline set for 5/4/2018. Release of Transcript Restriction set for 7/2/2018.(bpg) (Entered: 04/03/2018)

2018-04-03

1

View

[SEALED] Transcript of Bench Trial - Volume B held on February 13, 2018 before Chief Judge Leonard P. Stark. (bpg) (Entered: 04/03/2018)

2018-04-03

1

View

Official Transcript of Bench Trial - Volume C held on February 14, 2018 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone No. (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 4/24/2018. Redacted Transcript Deadline set for 5/4/2018. Release of Transcript Restriction set for 7/2/2018.(bpg) (Entered: 04/03/2018)

2018-04-03

1

View

Official Transcript of Bench Trial - Volume D held on February 15, 2018 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone No. (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 4/24/2018. Redacted Transcript Deadline set for 5/4/2018. Release of Transcript Restriction set for 7/2/2018.(bpg) (Entered: 04/03/2018)

2018-04-03

1

View

Official Transcript of Bench Trial - Volume E held on February 16, 2018 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone No. (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 4/24/2018. Redacted Transcript Deadline set for 5/4/2018. Release of Transcript Restriction set for 7/2/2018.(bpg) (Entered: 04/03/2018)

2018-04-03

1

View

NOTICE of Intent to Request Redaction by Anne Shea Gaza re 257 Transcript, 259 Transcript (Gaza, Anne) (Entered: 04/10/2018)

2018-04-10

1

View

[SEALED] POST TRIAL BRIEF Amneal's Responsive Post Trial Brief by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Gaza, Anne) (Entered: 04/13/2018)

2018-04-13

1

View

[SEALED] POST TRIAL BRIEF (Responsive) by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 04/13/2018)

2018-04-13

1

View

[SEALED] CORRECTED Proposed Findings of Fact by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Gaza, Anne) Modified on 4/16/2018 (ntl). (Entered: 04/13/2018)

2018-04-13

1

View

Letter to The Honorable Leonard P. Stark from Anne Shea Gaza regarding disks containing Defendants' hyperlinked post-trial briefing - re 264 POST Trial Brief, 266 Proposed Findings of Fact, 246 POST Trial Brief. (Gaza, Anne) (Entered: 04/19/2018)

2018-04-19

1

View

REDACTED VERSION of 265 POST Trial Brief by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 04/20/2018)

2018-04-20

1

View

REDACTED VERSION of 264 POST Trial Brief Amneal's Responsive Post-Trial Brief by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 04/20/2018)

2018-04-20

1

View

REDACTED VERSION of 266 Proposed Findings of Fact //Amneal's Corrected Proposed Findings of Fact by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 04/20/2018)

2018-04-20

1

View

MOTION to Redact 257 Transcript, 259 Transcript [Unopposed] - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Text of Proposed Order)(Wilson, Samantha) (Entered: 04/24/2018)

2018-04-24

1

View

[SEALED] EXHIBIT re 271 MOTION to Redact 257 Transcript, 259 Transcript [Unopposed] [Exhibits B and D] by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 04/24/2018)

2018-04-24

1

View

[SEALED] CORRECTED Proposed Findings of Fact by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) Modified on 4/30/2018 (ntl). (Main Document 273 replaced on 4/30/2018) (ntl). (Entered: 04/30/2018)

2018-04-30

1

View

REDACTED VERSION of 273 Proposed Findings of Fact by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 04/30/2018)

2018-04-30

1

View

CORRECTING ENTRY: DI 274 has been deleted at the request of the filer. (etg)

2018-04-30

1

No Actions

REDACTED VERSION of 272 Exhibit to a Document Exhibit B and D to Defendants' Unopposed Moton to Seal and Redact by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 05/01/2018)

2018-05-01

1

View

Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding hyperlinked briefs. (Noreika, Maryellen) (Entered: 05/02/2018)

2018-05-02

1

View

Redaction of 257 Transcript. Bench Trial - Volume A held on February 12, 2018 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone No. (302) 573-6360. (bpg) (Entered: 05/02/2018)

2018-05-02

1

View

Redaction of 259 Transcript. Bench Trial - Volume B held on February 12, 2018 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone No. (302) 573-6360. (bpg) (Entered: 05/02/2018)

2018-05-02

1

View

SO ORDERED, re 271 MOTION to Redact 257 Transcript, 259 Transcript [Unopposed] filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 5/2/18. (ntl)

2018-05-02

1

No Actions

Exhibit List by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 05/09/2018)

2018-05-09

1

View

Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amneal Pharmaceuticals, Inc., Corporate Parent APHC Holdings, LLC for Amneal Pharmaceuticals LLC; Corporate Parent Amneal Singapore Pvt. Ltd. for Amneal Pharmaceuticals Co. (I) Pvt. Ltd. filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Gaza, Anne) (Entered: 05/18/2018)

2018-05-18

1

View

NOTICE of Withdrawal of Co-Counsel by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC (Noreika, Maryellen) (Entered: 06/28/2018)

2018-06-28

1

View

NOTICE of Change of Firm Affiliation and Withdrawal of Appearance by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC (Noreika, Maryellen) (Entered: 07/11/2018)

2018-07-11

1

View

MOTION for Pro Hac Vice Appearance of Attorney Vanessa Y. Yen of KING & SPALDING LLP - filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 07/26/2018)

2018-07-26

1

View

[SEALED] Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding request for status conference. (Noreika, Maryellen) (Entered: 07/30/2018)

2018-07-30

1

View

SO ORDERED, re 283 MOTION for Pro Hac Vice Appearance of Attorney Vanessa Y. Yen of KING & SPALDING LLP filed by Galderma Laboratories L.P., TCD Royalty Sub LLC, Nestle Skin Health S.A. Signed by Judge Leonard P. Stark on 7/31/18. (ntl)

2018-07-31

1

No Actions

Pro Hac Vice Attorney Vanessa Y. Yen for Nestle Skin Health S.A., TCD Royalty Sub LLC, Galderma Laboratories, L.P. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:16-cv-01003-LPS, 1:16-cv-00207-LPS(crb)

2018-07-31

1

No Actions

ORAL ORDER: IT IS HEREBY ORDERED that a Status Telephone Conference is set for 8/8/2018 at 04:00 PM. Counsel for Plaintiffs shall initiate the call to (302) 573-4571. ORDERED by Judge Leonard P. Stark on 8/2/18. (ntl) (Entered: 08/02/2018)

2018-08-02

1

View

REDACTED VERSION of 284 Letter by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Blumenfeld, Jack) (Entered: 08/06/2018)

2018-08-06

1

View

Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 8/8/2018. (Court Reporter B. Gaffigan.) (ntl)

2018-08-08

1

No Actions

[SEALED] Transcript of Telephone Conference held on August 8, 2018 before Chief Judge Leonard P. Stark. (bpg) (Entered: 08/10/2018)

2018-08-10

1

View

NOTICE of Intent to Request Redaction by Samantha G. Wilson re 287 Transcript. (Wilson, Samantha) (Entered: 08/17/2018)

2018-08-17

1

View

[SEALED] OPINION re bench trial decision. Signed by Judge Leonard P. Stark on 8/27/18. This document has been emailed to local counsel. (ntl) (Entered: 08/27/2018)

2018-08-27

1

View

ORDER re 289 Opinion regarding bench trial decision. Signed by Judge Leonard P. Stark on 8/27/18. (ntl) (Entered: 08/27/2018)

2018-08-27

1

View

Letter to The Honorable Leonard P. Stark from Jeremy A. Tigan regarding proposed redactions pursuant to the Court's August 27, 2018 Order - re 290 Order. (Attachments: # 1 Proposed Redacted Opinion)(Tigan, Jeremy) (Entered: 08/29/2018)

2018-08-29

1

View

REDACTED PUBLIC VERSION of 289 Opinion. (ntl) (Entered: 08/31/2018)

2018-08-31

1

View

MOTION to Redact 287 Transcript (Unopposed) - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Attachments: # 1 Exhibit A, # 2 Text of Proposed Order)(Wilson, Samantha) (Entered: 08/31/2018)

2018-08-31

1

View

[SEALED] EXHIBIT re 293 MOTION to Redact 287 Transcript (Unopposed) - Exhibit B - by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 08/31/2018)

2018-08-31

1

View

Joint STATUS REPORT by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Proposed Judgment)(Blumenfeld, Jack) (Entered: 08/31/2018)

2018-08-31

1

View

JUDGMENT (See Judgment for further details) (CASE CLOSED). Signed by Judge Leonard P. Stark on 9/4/18. (ntl) (Entered: 09/04/2018)

2018-09-04

1

Download

REDACTED VERSION of 294 Exhibit to a Document - Exhibit B - by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Gaza, Anne) (Entered: 09/04/2018)

2018-09-04

1

View

ORDER re 293 MOTION to Redact 287 Transcript (Unopposed) filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 9/6/18. (ntl) (Entered: 09/06/2018)

2018-09-06

1

View

NOTICE OF APPEAL to the Federal Circuit of 296 Judgment . Appeal filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 10/01/2018)

2018-10-01

1

View

APPEAL - Credit Card Payment of $505.00 received re 299 Notice of Appeal (Federal Circuit) filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd.. ( Filing fee $505, receipt number 0311-2471833.) (Wilson, Samantha)

2018-10-01

1

No Actions

Notification regarding 299 Notice of Appeal (Federal Circuit) sent to Reporter Gaffigan (nmg)

2018-10-02

1

No Actions

Notification regarding 299 Notice of Appeal (Federal Circuit) sent to Reporter Gunning (nmg)

2018-10-02

1

No Actions

Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 299 Notice of Appeal (Federal Circuit). (nmg)

2018-10-02

1

No Actions

NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 299 Notice of Appeal (Federal Circuit) filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. USCA Case Number 19-1021. (ntl) (Entered: 10/04/2018)

2018-10-04

1

View

Redaction of 287 Transcript. (bpg) (Entered: 10/04/2018)

2018-10-04

1

View

NOTICE OF CROSS APPEAL to the Federal Circuit of 296 Judgment, 290 Order, 289 Opinion . Cross Appeal filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Blumenfeld, Jack) (Entered: 10/15/2018)

2018-10-15

1

View

TRANSCRIPT REQUEST by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC TRANSCRIPT ALREADY ON FILE (Wilson, Samantha) (Entered: 10/15/2018)

2018-10-15

1

View

APPEAL - Credit Card Payment of $505.00 received re 302 Notice of Cross Appeal filed by Galderma Laboratories L.P., TCD Royalty Sub LLC, Nestle Skin Health S.A.. ( Filing fee $505, receipt number 0311-2481346.) (Blumenfeld, Jack)

2018-10-15

1

No Actions

Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 302 Notice of Cross Appeal. (ceg)

2018-10-16

1

No Actions

Notification regarding 302 Notice of Cross Appeal sent to Reporter Gunning (ceg)

2018-10-16

1

No Actions

Notification regarding 302 Notice of Cross Appeal sent to Reporter Gaffigan (ceg)

2018-10-16

1

No Actions

NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 302 Notice of Cross Appeal filed by Galderma Laboratories L.P., TCD Royalty Sub LLC, Nestle Skin Health S.A. USCA Case Number 19-1093. (ntl) (Entered: 10/22/2018)

2018-10-22

1

View

ORDER of USCA as to 299 Notice of Appeal (Federal Circuit) filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Decision of USCA: motion for extension of time is granted. (ntl) (Entered: 02/11/2019)

2019-02-11

1

View

ORDER issued as MANDATE of USCA as to 302 Notice of Cross Appeal filed by Galderma Laboratories L.P., TCD Royalty Sub LLC, Nestle Skin Health S.A. USCA Decision: Motion to Voluntarily Dismiss Appeal is Granted. 2019-1093 is Dismissed. Each side shall bear its own costs in 2019-1093. (srs) (Entered: 04/19/2022)

2019-02-11

1

View

ORDER of USCA as to 299 Notice of Appeal (Federal Circuit) filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Decision of USCA: motion to redact brief is granted. (ntl) (Entered: 02/14/2019)

2019-02-14

1

View

JUDGMENT of USCA as to 299 Notice of Appeal (Federal Circuit) filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd., 302 Notice of Cross Appeal filed by Galderma Laboratories L.P., TCD Royalty Sub LLC, Nestle Skin Health S.A. Decision of USCA: Affirmed in part and Reversed in part. (Attachments: # 1 Opinion)(ntl) (Entered: 03/25/2020)

2020-03-25

1

View

ORDER of USCA as to 299 Notice of Appeal (Federal Circuit) filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd., 302 Notice of Cross Appeal filed by Galderma Laboratories L.P., TCD Royalty Sub LLC, Nestle Skin Health S.A. Decision of USCA: The petition for panel rehearing is denied. The petition for rehearing en banc is denied.The mandate of the court will issue on June 2, 2020. (ntl) (Entered: 05/26/2020)

2020-05-26

1

View

MANDATE of USCA as to 299 Notice of Appeal (Federal Circuit) filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. (ntl) (Entered: 06/02/2020)

2020-06-02

1

View

ORAL ORDER: IT IS HEREBY ORDERED that a joint status report shall be submitted no later than June 9, 2020. ORDERED by Judge Leonard P. Stark on 6/5/20. (ntl) (Entered: 06/05/2020)

2020-06-05

1

View

Order

2020-06-05

1

No Actions

Joint STATUS REPORT by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Blumenfeld, Jack) (Entered: 06/09/2020)

2020-06-09

1

View

Overview

Parties

Defendant

Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Follow

Represented By

Plaintiff

TCD Royalty Sub LLC Follow

Represented By

Galderma Laboratories L.P. Follow

Represented By

Counter Claimant

Amneal Pharmaceuticals LLC Follow

Represented By

Counter Defendant

Nestle Skin Health S.A. Follow

Represented By

Third Party Plaintiff

Irving Feit Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (aah) (Entered: 03/31/2016)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/18/2016. Date of Expiration of Patent: See attached form.Thirty Month Stay Deadline: 8/18/2018. (aah) (Entered: 03/31/2016)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,211,267 B2; 7,232,572 B2; 8,603,506 B2; 9,241,946 B2; 7,749,532 B2;(aah) (Entered: 03/31/2016)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Galderma General, L.L.C., Corporate Parent Galderma Limited, L.L.C., Corporate Parent Nestle Skin Health U.S. Inc. for Galderma Laboratories L.P. filed by Galderma Laboratories L.P.(aah) (Entered: 03/31/2016)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Nestle S.A. for Nestle Skin Health S.A. filed by Nestle Skin Health S.A.(aah) (Entered: 03/31/2016)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Royalty Opportunities S.a.r.l for TCD Royalty Sub LLC filed by TCD Royalty Sub LLC.(aah) (Entered: 03/31/2016)

Summons Issued

Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)

Case Assigned/Reassigned

SUMMONS Returned Executed by Nestle Skin Health S.A., Galderma Laboratories L.P., TCD Royalty Sub LLC. Amneal Pharmaceuticals LLC served on 4/20/2016, answer due 5/11/2016. (Noreika, Maryellen) (Entered: 04/22/2016)

SUMMONS Returned Executed by Nestle Skin Health S.A., Galderma Laboratories L.P., TCD Royalty Sub LLC. Amneal Pharmaceuticals Co. (I) Pvt. Ltd. served on 4/20/2016, answer due 5/11/2016. (Noreika, Maryellen) (Entered: 04/22/2016)

NOTICE of Change of Address by Maryellen Noreika (Noreika, Maryellen) (Entered: 05/05/2016)

ANSWER to 1 Complaint,, COUNTERCLAIM against Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Gaza, Anne) (Entered: 05/11/2016)

MOTION for Pro Hac Vice Appearance of Attorney Kevin Warner and Attorney Karalena M. Guerrieri - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 05/11/2016)

MOTION for Pro Hac Vice Appearance of Attorney Maureen L. Rurka - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 05/12/2016)

SO ORDERED, re 13 MOTION for Pro Hac Vice Appearance of Attorney Kevin Warner and Attorney Karalena M. Guerrieri filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 5/12/16. (ntl)

SO ORDERED

SO ORDERED, re 14 MOTION for Pro Hac Vice Appearance of Attorney Maureen L. Rurka filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 5/16/16. (ntl)

Pro Hac Vice Attorney Kevin E. Warner for Amneal Pharmaceuticals Co. (I) Pvt. Ltd., and Amneal Pharmaceuticals LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (klc)

SO ORDERED

Add Attorneys - PHV only

Add Attorneys - PHV only

ANSWER to 11 Answer to Complaint, Counterclaim by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 06/06/2016)

MOTION for Judgment on the Pleadings - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Attachments: # 1 Text of Proposed Order)(Gaza, Anne) (Entered: 06/16/2016)

OPENING BRIEF in Support re 16 MOTION for Judgment on the Pleadings filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.Answering Brief/Response due date per Local Rules is 7/5/2016. (Gaza, Anne) (Entered: 06/16/2016)

ANSWERING BRIEF in Opposition re 16 MOTION for Judgment on the Pleadings filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.Reply Brief due date per Local Rules is 7/15/2016. (Attachments: # 1 Exhibits A-E)(Blumenfeld, Jack) (Entered: 07/05/2016)

STIPULATION TO EXTEND TIME for Defendants to file a Reply Brief in support of their Motion for Partial Judgment on the Pleadings to July 22, 2106 - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Gaza, Anne) (Entered: 07/12/2016)

MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr., Evan D. Diamond, Vanessa Y. Yen and Andrew T. Kessel - filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 07/12/2016)

SO ORDERED, re 20 MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr., Evan D. Diamond, Vanessa Y. Yen and Andrew T. Kessel filed by Galderma Laboratories L.P., TCD Royalty Sub LLC, Nestle Skin Health S.A. Signed by Judge Leonard P. Stark on 7/13/16. (ntl)

SO ORDERED

SO ORDERED, re 19 STIPULATION TO EXTEND TIME for Defendants to file a Reply Brief in support of their Motion for Partial Judgment on the Pleadings to July 22, 2106 filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 7/13/16. (ntl)

SO ORDERED

REPLY BRIEF re 16 MOTION for Judgment on the Pleadings filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Gaza, Anne) (Entered: 07/22/2016)

REQUEST for Oral Argument by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC re 16 MOTION for Judgment on the Pleadings . (Gaza, Anne) (Entered: 07/22/2016)

Order

PROPOSED ORDER // Scheduling Order by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Attachments: # 1 Exhibit 1, # 2 Cover Letter)(Noreika, Maryellen) (Main Document 24 replaced on 9/8/2016) (ntl). (Attachment 1 replaced on 9/8/2016) (ntl). (Entered: 09/02/2016)

CORRECTING ENTRY: Corrected documents added to D.I. 24 per request of counsel. (ntl)

- CORRECTING ENTRY

STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to September 21, 2016 - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 09/14/2016)

NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Identifying Defendants' Accused Products and Plaintiffs' Asserted Patents filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 09/16/2016)

STIPULATION TO EXTEND TIME for parties to submit agreed modifications, if any, to the Default Standard for Discovery, including ESI to September 21, 2016 - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Gaza, Anne) (Entered: 09/16/2016)

SO ORDERED, re 25 STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to September 21, 2016 filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 9/19/16. (ntl)

SO ORDERED

NOTICE OF SERVICE of Defendants' Requests for Production of Documents and Things (Nos. 1-34) to Plaintiffs filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 09/21/2016)

STIPULATION TO EXTEND TIME for the parties to make their ESI Initial Disclosures, pursuant to the Proposed Scheduling Order to September 28, 2016 - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 09/23/2016)

SO ORDERED

SO ORDERED, re 30 STIPULATION TO EXTEND TIME for the parties to make their ESI Initial Disclosures, pursuant to the Proposed Scheduling Order to September 28, 2016 filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Signed by Judge Leonard P. Stark on 9/26/16. (ntl)

SO ORDERED

NOTICE OF SERVICE of Defendants' Initial Disclosures Under Paragraph 3 of the Stipulated Standard for Discovery filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 09/28/2016)

NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Parties' Proposed ESI Order filed by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC.(Noreika, Maryellen) (Entered: 09/28/2016)

PROPOSED ORDER // Protective Order by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 09/28/2016)

PROPOSED ORDER Regarding Discovery, Including Discovery of Electronically Stored Information ("ESI") by Galderma Laboratories L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC. (Noreika, Maryellen) (Entered: 09/28/2016)

SO ORDERED, re 34 Stipulated Order Regarding Discovery, Including Discovery of Electronically Stored Information ("ESI"); 33 Stipulated Protective Order. Signed by Judge Leonard P. Stark on 10/4/16. (ntl)

SO ORDERED

MOTION for Pro Hac Vice Appearance of Attorney Joanna F. Cornwell, Esquire - filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC. (Wilson, Samantha) (Entered: 10/07/2016)

NOTICE OF SERVICE of Defendants core technical documents, in accordance with Paragraph 7(b) of the Proposed Scheduling Order filed by Amneal Pharmaceuticals Co. (I) Pvt. Ltd., Amneal Pharmaceuticals LLC.(Wilson, Samantha) (Entered: 10/07/2016)

Order Setting Scheduling Conference

Amneal Pharmaceuticals Co. (I) Pvt. Ltd.

TCD Royalty Sub LLC

Galderma Laboratories L.P.

Amneal Pharmaceuticals LLC

Nestle Skin Health S.A.

Irving Feit